ATNF RSI Chart
Last 7 days
-18.1%
Last 30 days
-17.3%
Last 90 days
690%
Trailing 12 Months
51.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 | 25.9K |
2017 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 28, 2023 | feldmann marc | acquired | - | - | 135,377 | - |
Dec 15, 2023 | woody james n. | bought | 4,700 | 0.188 | 25,000 | chief executive officer |
Dec 15, 2023 | feldmann marc | sold | -4,700 | 0.188 | -25,000 | - |
Sep 04, 2023 | gold lawrence marshall | acquired | - | - | 21,455 | - |
Sep 04, 2023 | marrone pamela g | acquired | - | - | 22,388 | - |
Sep 04, 2023 | mcgovern jr. donald a. | acquired | - | - | 25,186 | - |
Sep 04, 2023 | ray russell t | acquired | 29,178 | 1.36 | 21,455 | - |
Jun 01, 2023 | steinman lawrence | bought | 22,068 | 1.226 | 18,000 | - |
May 31, 2023 | mcgovern jr. donald a. | bought | 11,470 | 1.147 | 10,000 | - |
May 19, 2023 | mcgovern jr. donald a. | bought | 5,800 | 1.16 | 5,000 | - |
Which funds bought or sold ATNF recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Semmax Financial Advisors Inc. | sold off | -100 | -1.00 | - | -% |
May 16, 2024 | Semmax Financial Advisors Inc. | new | - | 3.00 | 3.00 | -% |
May 15, 2024 | AQR Arbitrage LLC | added | 1,233 | 222 | 1,160 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 1,180 | 16.00 | 104 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -13,871 | - | -% |
May 15, 2024 | Royal Bank of Canada | new | - | - | - | -% |
May 15, 2024 | Royal Bank of Canada | sold off | -100 | - | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | sold off | -100 | -3,723 | - | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | added | 1,669 | 134 | 299 | -% |
May 15, 2024 | MSD Partners, L.P. | sold off | -100 | -378 | - | -% |
Unveiling 180 Life Sciences Corp.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to 180 Life Sciences Corp.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
180 Life Sciences Corp. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q4 | 2022Q3 | 2022Q2 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2017Q2 |
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55,729 |
Operating Expenses | -58.9% | 1,452,488 | 3,538,187 | 3,682,980 | 4,803,845 | 5,639,896 | - | - | - | 4,462,055 | 4,217,476 | 4,013,169 | 2,948,303 | 2,415,973 | 731,078 | 934,199 | 1,566,862 | - | - |
S&GA Expenses | -100.0% | - | 2,433,193 | 2,762,076 | 4,008,852 | 5,053,855 | - | - | - | 2,490,051 | 3,519,605 | 2,678,231 | 2,542,231 | -2,751,361 | 1,786,122 | 3,513,039 | 995,328 | 4,820,828 | - |
R&D Expenses | -100.0% | - | 972,113 | 789,441 | 578,309 | 503,360 | - | - | - | 324,668 | 316,473 | 246,613 | 99,899 | - | - | 351,005 | 472,862 | - | - |
EBITDA Margin | 49.1% | -857 | -1,684 | -2,026 | -1,771 | -1,527 | -612 | 920 | -96.51 | -777 | -1,102 | -1,836 | -915 | -381 | - | - | - | - | - |
Interest Expenses | 4.7% | 12,178 | 11,634 | 11,606 | 7,265 | 8,339 | - | - | - | 55,574 | 5,455 | 12,246 | 112,933 | 594,020 | 82,990 | 172,498 | 152,916 | - | - |
Income Taxes | 99.8% | -4,389 | -2,345,025 | - | - | - | - | - | - | -6,617 | -5,612 | -5,571 | -5,404 | -5,253 | -5,135 | -4,936 | -5,102 | -227,079 | - |
Earnings Before Taxes | 90.2% | -1,231,494 | -12,610,785 | -3,680,169 | -4,762,078 | -22,685,027 | - | - | - | 1,029,600 | 18,291,244 | -23,464,707 | -16,203,989 | -7,946,016 | -834,553 | 262,446 | -2,386,362 | -25,820,100 | - |
EBT Margin | 49.1% | -858 | -1,685 | -2,027 | -1,772 | -1,528 | -614 | 918 | -99.44 | -784 | -1,130 | -1,867 | -952 | -420 | - | - | - | - | - |
Net Income | 88.0% | -1,227,105 | -10,265,760 | -3,680,169 | -4,762,078 | -21,742,278 | - | - | - | 1,036,217 | 18,296,856 | -23,459,136 | -16,198,585 | -7,940,763 | -829,418 | 267,383 | -2,381,260 | -25,593,021 | - |
Net Income Margin | 50.7% | -768 | -1,559 | -1,991 | -1,736 | -1,492 | -614 | 918 | -98.76 | -783 | -1,129 | -1,866 | -952 | -419 | - | - | - | - | - |
Free Cashflow | -21.7% | -2,160,014 | -1,775,475 | -3,116,843 | -3,869,891 | -2,926,755 | -3,596,366 | -3,531,533 | -2,072,931 | -5,027,530 | -4,002,668 | -4,011,185 | -6,330,045 | -3,216,392 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -34.6% | 3,442 | 5,259 | 4,958 | 13,667 | 14,922 | 19,650 | 34,336 | 53,358 | 59,677 | 62,714 | 65,070 | 56,265 | 60,112 | 55,533 | 11,024 | 12,626 | 12,368 | 51,884 | 51,573 | 50,237 | 66,471 |
Current Assets | -49.0% | 1,855 | 3,640 | 3,371 | 2,934 | 4,196 | 8,928 | 6,515 | 4,647 | 8,957 | 11,201 | 13,634 | 4,046 | 8,298 | 4,015 | 721 | 1,186 | 388 | 748 | 901 | 209 | 145 |
Cash Equivalents | -65.8% | 676 | 1,976 | 2,663 | 2,009 | 2,646 | 6,970 | 3,589 | 1,625 | 5,669 | 8,225 | 11,688 | 1,836 | 6,053 | 2,109 | 33.00 | 70.00 | 98.00 | 83.00 | 836 | 110 | 135 |
Goodwill | - | - | - | - | - | - | 9,063 | 13,966 | 12,411 | 36,324 | 36,988 | 36,896 | 37,561 | 37,183 | 36,901 | - | - | - | 36,423 | - | - | - |
Liabilities | -18.4% | 4,396 | 5,387 | 5,107 | 6,951 | 7,783 | 8,306 | 8,261 | 10,566 | 18,773 | 23,391 | 27,929 | 53,549 | 37,403 | 25,247 | 6,277 | 4,142 | 7,238 | 13,314 | 6,813 | 5,456 | 5,203 |
Current Liabilities | -19.4% | 4,080 | 5,063 | 4,807 | 4,273 | 5,122 | 5,658 | 4,725 | 6,966 | 15,077 | 19,699 | 24,225 | 49,799 | 33,622 | 21,421 | 6,277 | 4,142 | 3,213 | 9,641 | 2,788 | 1,431 | 1,178 |
Shareholder's Equity | -647.2% | -954 | -127 | - | 6,716 | 7,140 | 11,344 | 26,075 | 42,791 | 40,905 | 39,323 | 37,141 | 2,716 | 22,709 | 30,287 | 35,467 | 35,882 | 34,747 | 38,571 | 5,000 | 5,000 | 5,000 |
Retained Earnings | -0.8% | -128,413 | -127,343 | -126,116 | -115,850 | -112,170 | -107,408 | -85,666 | -64,179 | -67,118 | -68,682 | -69,718 | -88,015 | -64,556 | -48,357 | -7,933 | -4,583 | 852 | -37,473 | 1,360 | 1,382 | 1,393 |
Additional Paid-In Capital | 0.2% | 130,354 | 130,117 | 128,815 | 125,466 | 122,195 | 121,638 | 115,427 | 108,786 | 107,930 | 107,187 | 106,154 | 89,496 | 86,436 | 78,005 | 12,680 | 9,583 | 4,147 | 75,890 | 3,639 | 3,618 | 3,607 |
Shares Outstanding | 59.5% | 853 | 535 | 355 | 197 | 197 | 197 | 103 | 90.00 | 90.00 | 90.00 | 80.00 | 83.00 | 74.00 | 69.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 5,851 | - | 25,377 | - | 25,377 | - | 271,883 | - | 20,792 | - | - | - | - | - | - | - | 50,159 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 52.2% | -1,033 | -2,160 | -1,775 | -3,116 | -3,869 | -2,926 | -3,596 | -3,531 | -2,072 | -5,027 | -4,002 | -4,011 | -6,330 | -3,216 | -53.97 | -192 | -409 | -2,158 | -216 | -636 | -307 |
Share Based Compensation | - | 236 | - | - | - | 557 | - | - | - | - | - | - | - | - | -1,506 | - | - | - | - | - | - | - |
Cashflow From Investing | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12,878 | 973 | 707 | -66.86 | -69,979 | -388 | 16,654 | 53,005 |
Cashflow From Financing | -118.0% | -264 | 1,468 | 2,447 | 2,462 | -469 | 6,396 | 5,488 | -494 | -515 | 1,549 | 13,729 | -228 | 10,363 | -9,225 | 147 | 12.00 | 333 | -38,962 | 1,330 | -16,041 | -52,834 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating Expenses: | ||
Research and development | $ 365,186 | $ 578,309 |
Research and development - related parties | 170,542 | 216,684 |
General and administrative | 1,556,740 | 4,008,852 |
Total Operating Expenses | 2,092,468 | 4,803,845 |
Loss From Operations | (2,092,468) | (4,803,845) |
Other (Expense) Income: | ||
Other income | 1,039,364 | |
Interest expense | (16,449) | (11,556) |
Change in fair value of derivative liabilities | (191) | 53,323 |
Total Other (Expense) Income, Net | 1,022,724 | 41,767 |
Loss Before Income Taxes | (1,069,744) | (4,762,078) |
Income tax benefit | ||
Net Loss | (1,069,744) | (4,762,078) |
Other Comprehensive Income (Loss): | ||
Foreign currency translation adjustments | 6,460 | 663 |
Total Comprehensive Loss | $ (1,063,284) | $ (4,761,415) |
Basic and Diluted Net Loss per Common Share | ||
Basic (in Dollars per share) | $ (1.68) | $ (24.15) |
Diluted (in Dollars per share) | $ (1.68) | $ (24.15) |
Weighted Average Number of Common Shares Outstanding: | ||
Basic (in Shares) | 638,339 | 197,219 |
Diluted (in Shares) | 638,339 | 197,219 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Assets | ||
Cash | $ 675,977 | $ 1,975,799 |
Prepaid expenses and other current assets | 1,178,971 | 1,664,107 |
Total Current Assets | 1,854,948 | 3,639,906 |
Intangible assets, net | 1,586,792 | 1,619,570 |
Total Assets | 3,441,740 | 5,259,476 |
Liabilities and Stockholders’ Deficit | ||
Accounts payable | 1,784,150 | 1,892,611 |
Accrued expenses | 1,416,790 | 1,869,814 |
Loans payable - current portion | 772,334 | 1,034,124 |
Derivative liabilities | 249 | 58 |
Total Current Liabilities | 4,080,307 | 5,062,616 |
Loans payable - noncurrent portion | 16,544 | 19,936 |
Deferred tax liability | 299,355 | 304,657 |
Total Liabilities | 4,396,206 | 5,387,209 |
Commitments and contingencies (Note 8) | ||
Stockholders’ Deficit: | ||
Preferred stock value | ||
Common stock, $0.0001 par value; 100,000,000 shares authorized; 852,772 and 534,719 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 86 | 54 |
Additional paid-in capital | 130,353,728 | 130,117,209 |
Accumulated other comprehensive income | (2,894,879) | (2,901,339) |
Accumulated deficit | (128,413,401) | (127,343,657) |
Total Stockholders’ Deficit | (954,466) | (127,733) |
Total Liabilities and Stockholders’ Deficit | 3,441,740 | 5,259,476 |
Related Party | ||
Liabilities and Stockholders’ Deficit | ||
Accounts payable – related parties | 53,076 | 266,009 |
Accrued expenses - related parties | 53,708 | |
Class C Preferred Stock | ||
Stockholders’ Deficit: | ||
Preferred stock value | ||
Class K Preferred Stock | ||
Stockholders’ Deficit: | ||
Preferred stock value |